Buy Ovid Therapeutics Stock | OVID Stock Price & Latest News | Public.com

Ovid Therapeutics

$0.00 (0.00%)Today

About OVID

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. The full company name is Ovid Therapeutics, Inc....

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1

Price Targets

What analysts think this stock will be worth

$7.16
current
$11.43
average

Events

List of events that could affect this stock.

07May

Earnings data Q1 2020

05Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.12
-0.25
-0.37
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.35

Actual EPS
Q3 2020

Stats

Market Cap$393,68M
Volume26,24k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$9.40
1 Year Low$1.74
Open$7.19
High$7.28
Low$6.95

Buy any stock with any amount of money.

Download the App
Download the app